A study to investigate effects of Probiotics (Bifidobacteria) ingestion on visceral fat area in overweight adult: a randomized, double blind, placebo controlled study.
Not Applicable
- Conditions
- one
- Registration Number
- JPRN-UMIN000023919
- Lead Sponsor
- KSO Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Subjects who have history or receiving treatment of serious disease (2) Subject with gastrointestinal related disease and undertake medication (3) Subject who is under medication for diabetes, hypertension or dyslipidemia (4) Subject with a history of serious allergy to medicine and food (5) Subject who is pregnant or under lactation, or who is expected to be pregnant during the study (6) Heavy smoker and heavy drinker, or subject with irregular lifestyle (7) Subject who is ineligible due to physician's judgment based on background of subject, physical finding, interview
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method abdominal visceral fat area (Time frame: 12 weeks)
- Secondary Outcome Measures
Name Time Method Body composition (body weight, body fat mass, body fat percentage, BMI, visceral fat area, subcutaneous fat area, total fat area), Waist circumference, Serum lipids (Total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides), Diabetes associated markers (fasting plasma glucose, HbA1c, glycoalbumin, fasting serum insulin), liver function (AST, ALT, gamma-GTP, ALP), inflammatory marker (hs-CRP, LBP), enteric environment (enterobacterial flora analysis, defecation frequency)